US · Healthcare

Evofem Biosciences Inc (EVFM)

Biotechnology

Evofem Biosciences Inc (EVFM) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for EVFM

P/E ratio

25.00

Evofem Biosciences Inc (EVFM) — FAQ

What is EVFM's P/E ratio?

The price-to-earnings (P/E) ratio for Evofem Biosciences Inc (EVFM) is 25.00 (data as of 2026-05-23).

Does Evofem Biosciences Inc pay a dividend?

Dividend yield is not available in the current snapshot for Evofem Biosciences Inc (EVFM). Check the MyAverix Finance app for the latest dividend data.

What sector is Evofem Biosciences Inc in?

Evofem Biosciences Inc (EVFM) is classified in the Healthcare sector (Biotechnology industry).

What exchange is EVFM listed on?

EVFM is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)